SGLT2 inhibition and heart failure: time to think differently? - Heart failure: The whole picture in 5 minutes

Lessons learnt from recent clinical trial outcomes - Why was CANTOS positive - What can we learn for basic science?

Interpretation of biomarkers in chronic heart failure – Easier said than done - Established biomarkers - Who is hot and who is not?

Acute heart failure: from drugs to devices and back - Mihai Gheorghiade lecture - The future in heart failure therapeutics: restore and regenerate

Atrial fibrillation and HFpEF - Just twins? - Pharmacological therapies in atrial fibrillation and HFpEF

Rene Lerch Session - Gaps in evidence - HFmrEF - Playground for subgroup analysts or a real clinical problem?

Heart failure as a major local and global challenge in the 21st century - Epidemiology in Hungary

GRAND DEBATE I - Drugs or interventions - The beat goes on - Coronary revascularisation provides no meaningful clinical benefit over optimal medical therapy in patients with stable ischaemic heart failure - CONTRA